ArticleJournal of inflammation research2026
Early Prediction of Primary Non-Response to Infliximab in Crohn's Disease Using Routinely Available Clinical and Week 2 Laboratory Indicators: A Two-Center Real-World Cohort Study.
Meihua Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.